Jazz Glastra is Senior Director of Program Operations at BrainFutures, which just published its latest brief: Psychedelic Access Pathways. Here, Glastra delineates three distinct contexts in which psychedelics are regulated in the U.S. and proposes that we be mindful of these distinctions when discussing psychedelic use. Given the emergence of psychedelic policy reform experiments like those in…


Previous articleFirst clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine
Next articlePT426 – Making the Impossible Possible: Flow Hacking and Peak Performance Aging